Find out how you can help keep yourself well this Winter and reduce your risks associated with COVID-19. Click below to find out more:
Diabetes and Research
Would you like to get involved with research? If you would, we have two studies for people with type 2 diabetes currently taking place.
1) BI 456906, sponsored by Boehringer Ingelheim Ltd.
This study is to test whether different doses of BI 456906 are effective in treating adults with type 2 diabetes. This phase II study randomises people to different groups and compares the drug BI 456906 with a placebo and semaglutide, a diabetes medicine. Patients with diagnosed type 2 diabetes mellitus and who have insufficient glycaemic control despite diet, exercise, and metformin treatment will be welcome to take part in the trial.
What will happen to me if I take part? Your participation is voluntary. If you would like to take part you will be invited to come to the Research & Development trial clinic for a 1 hour screen visit. If you’re eligible for the study, your participation in the trial will last approximately 23 weeks and require approximately 13 visits to the trial clinic. If you’re in one of the groups receiving the injection twice a week, you will have about 20 visits to the trial clinic. For your time and inconvenience related to taking part in this study, and to take account of any loss of earnings, the sponsor will pay the costs of £30 per visit (plus £10 if you’re assigned to group which need to come to clinic twice per week).
To take part you must meet the following criteria:
- Participant is willing and able to give informed consent for participation in the study;
- Participant is 18 years to 75 years of age on the day of signing informed consent;
- Diagnosis of type 2 diabetes mellitus at least 6 months prior to informed consent;
- Treatment with a stable dose of metformin >=1000mg/day for at least 3 months;
- BMI 25kg/m2 - 50kg/m2.
If you would like to take part or want more information, please email Qi Zheng on email@example.com or phone 02380 475258.
2) Quality of Life in Diabetes
This type 2 diabetes study compares the effects of oral treatment and injectable treatments on quality of life and is now recruiting to the end of December. If you are starting on a new oral medication or an injectable treatment for the first time please email Liz Houghton on firstname.lastname@example.org with your details, or phone 02380 475258.
We will be having some more studies starting to shortly so if you would like to get involved please do contact us.
FreeStyle Libre 2 Information
There is a new version of the FreeStyle Libre system called FreeStyle Libre 2 or FSL 2 which is now available.
In order to prepare you may want to consider ordering a new FSL 2 Reader device (for free) from Abbott if you use the Reader to scan with. Click here to order one.
Click here to find out more about moving to FSL2.
Your surgery will be able to add the new FSL 2 sensors to your prescription if you request this via email or via dashboard, or ask at your next appointment to change over.
In the meantime, you can continue to use your Freestyle Libre as you are doing.
Click here to read more about the FSL2 update.
ABBOTT Information about FSL2:
Tutorial | FreeStyle Glucose Meters
Libre Academy has FSL 2 module added (you need to register and log in to access):
To ensure all people with diabetes have access to excellent skills and knowledge so you can achieve your individual goals and become active participants in your care whenever possible.
Our awarding winning specialist team of Diabetes Nurses, Dietitians and Consultants work alongside people diagnosed with diabetes across West and North Hampshire. We aim to provide holistic care, supporting people who have been diagnosed to self-manage (where possible) and we link with other local specialist services such as italk, doctors surgeries and community care teams.
We also have a large portfolio of diabetes education courses that can help people to understand their diagnosis and achieve their goals. It's a great opportunity to meet other people.